Ibl Healthcare Limited operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Ibl Healthcare Limited with three other
drug stores in Asia:
Immuno-Biological Laboratories Company Limited
sales of 741.53 million Japanese Yen [US$6.70 million]
of which 74%
was Diagnosis & Reagent),
FCW Holdings Berhad
(26.70 million Malaysian Ringgits [US$6.78 million]
Extrawell Pharmaceutical Holdings Limited
based in Hong Kong
(107.90 million Hong Kong Dollars [US$13.80 million]
of which 59%
Ibl Healthcare Limited reported sales of 1.19 billion Pakistan Rupees (US$10.74 million)
June of 2017.
increase of 2.9%
versus 2016, when the company's sales were 1.16 billion Pakistan Rupees.
Sales at Ibl Healthcare Limited have increased during each of the previous five years
(and since 2012, sales have increased a total of 64%).